AiM Medical Robotics Announces Collaboration with Brigham Women’s Hospital for MRI-Compatible Surgical Robot Validation in Parkinson’s Patients

AiM Medical Robotics Inc. has made significant strides in the field of neurosurgery with their collaboration with Brigham Women’s Hospital (BWH) to validate an MRI-compatible surgical robot for deep brain stimulation (DBS) in Parkinson’s patients. This groundbreaking partnership aims to revolutionize the precision and efficacy of neurosurgical procedures.

The successful cadaver trial conducted by AiM showcased the precise delivery of bilateral DBS leads using real-time MRI guidance, highlighting the robot’s ability to account for brain shift during surgery. This demonstration is a significant advancement in ensuring accurate targeting and successful outcomes for patients undergoing DBS procedures.

Additionally, AiM announced a collaboration with Synaptive Medical to integrate neuro-navigation software, enhancing the workflow for unparalleled precision in neurosurgery. By combining AiM’s cutting-edge technology with Synaptive’s advanced software, the partnership aims to improve visualization, navigation, and control during deep brain interventions.

The collaboration with Brigham Women’s Hospital and Synaptive Medical marks a significant milestone for AiM Medical Robotics, positioning them as leaders in the development of MRI-compatible robotics for neurosurgery. With a focus on addressing challenges related to brain shift and improving patient outcomes, AiM is poised to make a significant impact in the field of neurosurgery.

The company’s innovative approach, backed by years of research and development, has the potential to transform the way neurosurgical procedures are performed. By introducing intraoperative MRI guidance as a routine practice, AiM aims to improve hospital throughput, procedural consistency, and ultimately, patient outcomes.

Overall, AiM Medical Robotics’ collaboration with Brigham Women’s Hospital and Synaptive Medical represents a significant step forward in advancing the field of neurosurgery and improving the quality of care for patients undergoing DBS procedures.